Category

Healthcare

Category

In briefThe long awaited Implementing Regulations under Federal Law No. 2 of 2019 concerning the Use of the Information and Communication Technology in the Areas of Health (the “Health Data Law”) were finally issued on 22 April 2020 in the form of Cabinet Resolution No. 32 of 2020 (the “HDL Regulations”). Understandably, in light of the current global health pandemic, the UAE Ministry of Health (MOH) is focusing its efforts on implementing the legal framework…

The pervasive nature of COVID-19 means that organisations globally and in the Middle East are facing a similar struggle: navigating both the short-term and long-term business implications of the pandemic. Whether managing the immediate crisis, stabilizing your operations or evolving your business model, it is critical for your organization to navigate the various regulatory developments and changes that vary by country and consider the risks and opportunities that may impact your business.Baker McKenzie is pleased…

On 15 April 2020, based on a study presented by the Egyptian Competition Authority (ECA), the Prime Minister issued Decision No. 17/2020 fixing the prices of some products needed to combat COVID-19 for at least three months ending on 14 July 2020 (the Decision). This Decision is the first successful implementation of Article 10 of the Egyptian Competition Law (ECL), which grants the Council of Ministers the right to fix the prices of strategic/essential product(s)…

On 19 December 2019, the UAE government adopted a new federal law which replaces Law No. 4 of 1983 on the Pharmacy Professional and Pharmaceutical Establishments and Law No. 20 of 1995 on the Drugs and Products. Law No. 8 of 2019 on Medical Products, Pharmacy Profession and Pharmaceutical Establishments (the new Law) aims to consolidate and modernise the legal framework under which medical products are placed on the UAE market. The new Law applies…